Nanhua Biotech: Nanhua Biotech\'s Announcement on Independent Directors Obtaining Independent Director Qualification Certificates
Nanhua Biotech: Legal Opinion on Nanhua Biotech\'s 2024 Second Extraordinary General Meeting of Shareholders
Nanhua Biotech: Announcement of Resolutions of Nanhua Biotech\'s 2024 Second Extraordinary General Meeting of Shareholders
Nanhua Biotech: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
Nanhua Biotech: Nanhua Biotech\'s announcement on plans to change the company\'s independent directors and adjust the members of the special committee of the board of directors
Nanhua Biotech: Semi-annual summary of non-operating capital consumption and other related capital transactions
Nanhua Biotech: 2024 Semi-Annual Financial Report
Landfar Bio-medicine: Announcement on the Progress of Litigation Matters of Subsidiary Controlled by Landfar Bio-Medicine
Landfar Bio-medicine: Announcement about the Resignation of Independent Director of Landfar Bio-Medicine.
Landfar Bio-medicine: Announcement on Landfar Bio-Medicine's Lawsuit Against its Holding Subsidiary
Landfar Bio-medicine: Announcement of the Progress of Legal Proceedings Regarding the Controlling Subsidiary of Landfar Bio-Medicine
Landfar Bio-medicine: Announcement of Landfar Bio-Medicine on Filing a Lawsuit against Its Subsidiary
Landfar Bio-medicine: Announcement on the Progress of Litigation Matters of Subsidiary Controlled by Landfar Bio-Medicine
Landfar Bio-medicine: Announcement of Resolutions of Nanhua Biotech's 2023 Annual General Meeting of Shareholders
Landfar Bio-medicine: Legal Opinion on Nanhua Biotech's 2023 Annual General Meeting of Shareholders
Landfar Bio-medicine: Announcement of Nanhua Biotech on changing the registered capital, amending the “Articles of Association”, and completing the registration of industrial and commercial changes
Landfar Bio-medicine: Report on the performance of the Audit Committee of the Board of Directors in 2023
Landfar Bio-medicine: Nanhua Biotech's announcement on plans not to distribute profits in 2023
Landfar Bio-medicine: Internal Control Self-Assessment Report
Landfar Bio-medicine: Nanhua Biotech 2023 Goodwill Impairment Test Report
No Data
No Data